Erratum: Telavancin for hospital-Acquired pneumonia: Clinical response and 28-day survival (Antimicrobial Agents and Chemotherapy (2014) 58:4 (2030-2037))

G. Ralph Corey, Marin H. Kollef, Andrew F. Shorr, Ethan Rubinstein, Martin E. Stryjewski, Alan Hopkins, Steven L. Barriere

Research output: Contribution to journalComment/debate

Fingerprint

Dive into the research topics of 'Erratum: Telavancin for hospital-Acquired pneumonia: Clinical response and 28-day survival (Antimicrobial Agents and Chemotherapy (2014) 58:4 (2030-2037))'. Together they form a unique fingerprint.